All Resources

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

Download PDF

High Priority Status: No / N/A

CBE Number: N/A

Measure Description:

Percentage of patients aged 2 years and older with a diagnosis of allergic rhinitis who are prescribed or recommended intranasal corticosteroids (INS) or non-sedating oral antihistamines.


This measure is to be submitted a minimum of once per performance period for patients diagnosed with allergic rhinitis. This measure may be submitted by clinicians based on the services provided and the measure-specific denominator coding.


All patients aged 2 years and older with a diagnosis of allergic rhinitis.

Denominator Note:

To meet the denominator criteria, a patient must have been diagnosed with allergic rhinitis at the time of an encounter. This includes new onset and existing allergic rhinitis diagnoses.

Denominator Exclusions:



Patients who are prescribed or recommended intranasal steroids (INS) or non-sedating oral antihistamines.

A prescription for or medication reconciliation of over-the-counter medications can be used to identify patients taking medications.

Numerator Note:

To meet the intent of the measure, the numerator quality action must be performed at the encounter in which the active diagnosis of allergic rhinitis is documented.

Denominator Exceptions

  • Patients with an allergy to oral antihistamines or intranasal corticosteroids.
  • Patients with prostate cancer or benign prostatic hypertrophy as these patients may be intolerant of medications.
  • Patients with a history of epistaxis due to intranasal steroid use.
  • Patients with glaucoma.
  • Patient refusal.

Measure Classifications

  • Submission Pathway: Traditional MIPS, MIPS Value Pathways
  • Measure Type: Process
  • Meaningful Measures Area: Medication Management
  • Care Setting(s): Ambulatory Care: Clinician Office/Clinic
  • Includes Telehealth: Yes
  • Number of Performance Rates: 1
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No


© 2023 American Academy of Otolaryngology–Head and Neck Surgery Foundation. All rights reserved.

Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the measures for commercial gain, or incorporation of the measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the measures require a license agreement between the user and the American Academy of Otolaryngology – Head and Neck Surgery Foundation.


The measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. The measure and specifications are provided “as is” without warranty of any kind. Neither the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), nor its members shall be responsible for any use of the measure. The AAO-HNSF and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

AAO-HNS COVID-19 InformationLearn More